SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 43 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,585,000 | -4.5% | 2,060,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,706,000 | -85.2% | 2,060,000 | -83.5% | 0.00% | -85.0% |
| Q4 2021 | $18,337,000 | -22.6% | 12,500,000 | -21.9% | 0.02% | -25.9% |
| Q3 2021 | $23,700,000 | +3.5% | 16,000,000 | -8.6% | 0.03% | -3.6% |
| Q1 2021 | $22,903,000 | -58.5% | 17,500,000 | -22.2% | 0.03% | -60.0% |
| Q4 2020 | $55,221,000 | +32.2% | 22,500,000 | +11.8% | 0.07% | +18.6% |
| Q3 2020 | $41,779,000 | +102.1% | 20,125,000 | +123.6% | 0.06% | +84.4% |
| Q2 2020 | $20,677,000 | +36.0% | 9,000,000 | -10.0% | 0.03% | +14.3% |
| Q1 2020 | $15,203,000 | +212.3% | 10,000,000 | +300.0% | 0.03% | +300.0% |
| Q4 2019 | $4,868,000 | -88.5% | 2,500,000 | -86.8% | 0.01% | -89.9% |
| Q2 2019 | $42,340,000 | +55.8% | 19,000,000 | +26.6% | 0.07% | +56.8% |
| Q1 2019 | $27,181,000 | – | 15,012,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 53,865,000 | $101,127,280 | 3.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,657,000 | $165,397,613 | 3.42% |
| Boussard & Gavaudan Investment Management LLP | 11,898 | $21,871,538 | 2.42% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,394,000 | $71,834,226 | 1.71% |
| WOLVERINE ASSET MANAGEMENT LLC | 79,876,000 | $149,367,384 | 1.55% |
| CSS LLC/IL | 4,747,000 | $8,868,606 | 0.50% |
| Opti Capital Management, LP | 3,000,000 | $5,611,938 | 0.48% |
| Verition Fund Management LLC | 16,459,000 | $30,786,560 | 0.48% |
| Aequim Alternative Investments LP | 5,000,000 | $9,352,500 | 0.25% |
| MIZUHO SECURITIES USA LLC | 1,097,000 | $2,047,616 | 0.19% |